{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:40:57Z","timestamp":1781606457826,"version":"3.54.5"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.molimm.2022.11.020","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:45:06Z","timestamp":1669297506000},"page":"10-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches"],"prefix":"10.1016","volume":"156","author":[{"given":"Shahrzad","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Bazargan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolreza","family":"Esmaeilzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"83\u201385","key":"10.1016\/j.molimm.2022.11.020_bib1","first-page":"7","article-title":"A comprehensive review on Covid-19 Delta variant","volume":"5","author":"Alexandar","year":"2021","journal-title":"Int. J. Pharmacol. Clin. Res. (IJPCR)"},{"issue":"2","key":"10.1016\/j.molimm.2022.11.020_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cei.13523","article-title":"Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage","volume":"202","author":"Amor","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2022.11.020_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757197","article-title":"Functional effects of receptor-binding domain mutations of SARS-CoV-2 B.1.351 and P.1 variants","volume":"12","author":"Bayarri-Olmos","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2022.11.020_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100306","article-title":"SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis","volume":"296","author":"Bayati","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2022.11.020_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3435","article-title":"OMICRON: virology, Immunopathogenesis, and laboratory diagnosis","author":"Bazargan","year":"2022","journal-title":"J. Gene Med."},{"issue":"6","key":"10.1016\/j.molimm.2022.11.020_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167265","article-title":"Mechanisms of antiviral immune evasion of SARS-CoV-2","volume":"434","author":"Beyer","year":"2022","journal-title":"J. Mol. Biol."},{"issue":"7898","key":"10.1016\/j.molimm.2022.11.020_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift","volume":"602","author":"Cameroni","year":"2022","journal-title":"Nature"},{"issue":"6518","key":"10.1016\/j.molimm.2022.11.020_bib8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Sci. (N. Y., NY)"},{"issue":"17","key":"10.1016\/j.molimm.2022.11.020_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00071-17","article-title":"Going against the tide: selective cellular protein synthesis during virally induced host shutoff","volume":"91","author":"Cao","year":"2017","journal-title":"J. Virol."},{"issue":"7898","key":"10.1016\/j.molimm.2022.11.020_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"7898","key":"10.1016\/j.molimm.2022.11.020_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","article-title":"Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron","volume":"602","author":"Carre\u00f1o","year":"2022","journal-title":"Nature"},{"issue":"7898","key":"10.1016\/j.molimm.2022.11.020_bib12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization","volume":"602","author":"Cele","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2022.11.020_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.757238","article-title":"Inhibition of PKR by viruses","volume":"12","author":"Cesaro","year":"2021","journal-title":"Front. Microbiol."},{"issue":"50","key":"10.1016\/j.molimm.2022.11.020_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111011118","article-title":"Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells","volume":"118","author":"Chen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/01.PDR.0000129184.87042.FC","article-title":"SARS: the first pandemic of the 21st century","volume":"56","author":"Cherry","year":"2004","journal-title":"Pedia Res"},{"issue":"11","key":"10.1016\/j.molimm.2022.11.020_bib16","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","article-title":"Immune response in COVID-19: a review","volume":"13","author":"Chowdhury","year":"2020","journal-title":"J. Infect. Public Health"},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","article-title":"SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses","volume":"185","author":"Dejnirattisai","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2022.11.020_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.693775","article-title":"Crucial mutations of spike protein on SARS-CoV-2 evolved to variant strains escaping neutralization of convalescent plasmas and rbd-specific monoclonal antibodies","volume":"12","author":"Ding","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2022.11.020_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.coviro.2015.07.002","article-title":"Inhibition of the OAS\/RNase L pathway by viruses","volume":"15","author":"Drappier","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.molimm.2022.11.020_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108536","article-title":"An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)","author":"Elahi","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.molimm.2022.11.020_bib21","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/jcp.30076","article-title":"Immunobiology and immunotherapy of COVID-19: a clinically updated overview","volume":"236","author":"Esmaeilzadeh","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.molimm.2022.11.020_bib22","series-title":"Coronavirus Disease-COVID-19","first-page":"449","article-title":"Immune-based therapy for COVID-19","author":"Esmaeilzadeh","year":"2021"},{"issue":"10","key":"10.1016\/j.molimm.2022.11.020_bib23","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/jcb.30017","article-title":"Recent advances in antibody-based immunotherapy strategies for COVID-19","volume":"122","author":"Esmaeilzadeh","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molimm.2022.11.020_bib24","doi-asserted-by":"crossref","unstructured":"Finkel Y., Gluck A., Winkler R., Nachshon A., Mizrahi O., Lubelsky Y., et al. SARS-CoV-2 utilizes a multipronged strategy to suppress host protein synthesis. bioRxiv. 2020:2020.11.25.398578.","DOI":"10.1101\/2020.11.25.398578"},{"key":"10.1016\/j.molimm.2022.11.020_bib25","doi-asserted-by":"crossref","unstructured":"Fisher T., Gluck A., Narayanan K., Kuroda M., Nachshon A., Hsu J.C., et al. Parsing the role of NSP1 in SARS-CoV-2 infection. bioRxiv. 2022.","DOI":"10.1101\/2022.03.14.484208"},{"key":"10.1016\/j.molimm.2022.11.020_bib26","doi-asserted-by":"crossref","unstructured":"Flower T.G., Buffalo C.Z., Hooy R.M., Allaire M., Ren X., Hurley J.H. Structure of SARS-CoV-2 ORF8, a rapidly evolving coronavirus protein implicated in immune evasion. bioRxiv. 2020.","DOI":"10.1101\/2020.08.27.270637"},{"issue":"17","key":"10.1016\/j.molimm.2022.11.020_bib27","doi-asserted-by":"crossref","first-page":"10136","DOI":"10.1093\/nar\/gkab719","article-title":"Characterization of SARS2 Nsp15 nuclease activity reveals it's mad about U","volume":"49","author":"Frazier","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.molimm.2022.11.020_bib28","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.7150\/ijbs.59943","article-title":"SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3","volume":"17","author":"Fung","year":"2021","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.molimm.2022.11.020_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119503","article-title":"Risk factors for adverse outcomes of COVID-19 patients: possible basis for diverse responses to the novel coronavirus SARS-CoV-2","volume":"277","author":"Ghaebi","year":"2021","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.molimm.2022.11.020_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/v14061273","article-title":"Nucleopore traffic is hindered by SARS-CoV-2 ORF6 protein to efficiently suppress IFN-\u03b2 and IL-6 secretion","volume":"14","author":"Gori Savellini","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-022-01783-5","article-title":"The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity","volume":"19","author":"Gu","year":"2022","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12985-022-01783-5","article-title":"The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity","volume":"19","author":"Gu","year":"2022","journal-title":"Virol. J."},{"key":"10.1016\/j.molimm.2022.11.020_bib35","doi-asserted-by":"crossref","unstructured":"Hachmann N.P., Miller J., Collier A.Y., Ventura J.D., Yu J., Rowe M., et al. Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. The New England journal of medicine. 2022.","DOI":"10.1101\/2022.05.16.22275151"},{"issue":"5","key":"10.1016\/j.molimm.2022.11.020_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5144\/0256-4947.2013.427","article-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV): a perpetual challenge","volume":"33","author":"Hajjar","year":"2013","journal-title":"Ann. Saudi Med"},{"issue":"8","key":"10.1016\/j.molimm.2022.11.020_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010349","article-title":"SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export","volume":"18","author":"Hall","year":"2022","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.molimm.2022.11.020_bib38","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1002\/jmv.27050","article-title":"SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I\/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways","volume":"93","author":"Han","year":"2021","journal-title":"J. Med Virol."},{"issue":"7","key":"10.1016\/j.molimm.2022.11.020_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.molimm.2022.11.020_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109126","article-title":"Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities","volume":"35","author":"Hayn","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.molimm.2022.11.020_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2567.2003.01738.x","article-title":"The MHC class I antigen presentation pathway: strategies for viral immune evasion","volume":"110","author":"Hewitt","year":"2003","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","article-title":"The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic","volume":"185","author":"Hoffmann","year":"2022","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.molimm.2022.11.020_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101161118","article-title":"Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein","volume":"118","author":"Hsu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib44","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/s41467-020-19619-7","article-title":"SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography","volume":"11","author":"Klein","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2022.11.020_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636966","article-title":"Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers","volume":"12","author":"Knyazev","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2022.11.020_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.700926","article-title":"RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses","volume":"12","author":"Kouwaki","year":"2021","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib47","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib48","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.molimm.2022.11.020_bib49","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41423-021-00807-4","article-title":"SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy","volume":"19","author":"Li","year":"2022","journal-title":"Cell Mol. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2022.11.020_bib51","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"issue":"7898","key":"10.1016\/j.molimm.2022.11.020_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"7\u20138","key":"10.1016\/j.molimm.2022.11.020_bib53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/17534259211051364","article-title":"TLRs in COVID-19: how they drive immunopathology and the rationale for modulation","volume":"27","author":"Mabrey","year":"2021","journal-title":"Innate Immun."},{"key":"10.1016\/j.molimm.2022.11.020_bib54","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1016\/j.csbj.2021.07.023","article-title":"Immune evasion of SARS-CoV-2 from interferon antiviral system","volume":"19","author":"Min","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"45","key":"10.1016\/j.molimm.2022.11.020_bib55","doi-asserted-by":"crossref","first-page":"28344","DOI":"10.1073\/pnas.2016650117","article-title":"SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling","volume":"117","author":"Miorin","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.molimm.2022.11.020_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3303","article-title":"COVID\u201019: virology, biology and novel laboratory diagnosis","volume":"23","author":"Mohamadian","year":"2021","journal-title":"J. Gene Med."},{"key":"10.1016\/j.molimm.2022.11.020_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107051","article-title":"The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: vaccine design strategies","volume":"92","author":"Molaei","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/22221751.2020.1870414","article-title":"SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species","volume":"10","author":"Moustaqil","year":"2021","journal-title":"Emerg. Microbes Infect."},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030530","article-title":"SARS-CoV-2 nucleocapsid protein targets RIG-I-like receptor pathways to inhibit the induction of interferon response","volume":"10","author":"Oh","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-022-00992-2","article-title":"Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events","volume":"7","author":"Ou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib61","first-page":"268","article-title":"Protective and pathogenic role of humoral responses in COVID-19","volume":"60","author":"Park","year":"2022","journal-title":"J. Microbiol. (Seoul., Korea)"},{"issue":"12","key":"10.1016\/j.molimm.2022.11.020_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108890","article-title":"The effect of spike mutations on SARS-CoV-2 neutralization","volume":"34","author":"Rees-Spear","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101041","article-title":"The SARS-CoV-2 Nsp3 macrodomain reverses PARP9\/DTX3L-dependent ADP-ribosylation induced by interferon signaling","volume":"297","author":"Russo","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.molimm.2022.11.020_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008737","article-title":"Interplay between SARS-CoV-2 and the type I interferon response","volume":"16","author":"Sa Ribero","year":"2020","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.molimm.2022.11.020_bib65","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jmv.27524","article-title":"Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective","volume":"94","author":"Saxena","year":"2022","journal-title":"J. Med. Virol."},{"issue":"19","key":"10.1016\/j.molimm.2022.11.020_bib66","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1128\/JVI.00784-08","article-title":"The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex","volume":"82","author":"Schaecher","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2022.11.020_bib67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fimmu.2013.00483","article-title":"Type I interferons as stimulators of DC-mediated cross-priming: impact on anti-tumor response","volume":"4","author":"Schiavoni","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2022.11.020_bib68","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fimmu.2018.00678","article-title":"The CD8 T cell response to respiratory virus infections","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2022.11.020_bib69","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.molimm.2022.11.020_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of immune response during SARS-CoV-2 infection: lessons from the past","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2022.11.020_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/jgv.0.001513","article-title":"Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression","volume":"102","author":"Shen","year":"2021","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.molimm.2022.11.020_bib72","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses","volume":"27","author":"Shi","year":"2020","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib73","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.emboj.7601977","article-title":"Messenger RNA regulation: to translate or to degrade","volume":"27","author":"Shyu","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.molimm.2022.11.020_bib74","article-title":"Recent insights into SARS-CoV-2 omicron variant","author":"Silva","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.molimm.2022.11.020_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580641","article-title":"Covid-19: perspectives on innate immune evasion","volume":"11","author":"Taefehshokr","year":"2020","journal-title":"Front. Immunol."},{"issue":"6508","key":"10.1016\/j.molimm.2022.11.020_bib76","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1126\/science.abc8665","article-title":"Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2","volume":"369","author":"Thoms","year":"2020","journal-title":"Sci. (N. Y., NY)"},{"issue":"5","key":"10.1016\/j.molimm.2022.11.020_bib77","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","article-title":"Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity","volume":"184","author":"Thomson","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2022.11.020_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00182","article-title":"Understanding MHC Class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines","volume":"5","author":"van Montfoort","year":"2014","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2022.11.020_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253089","article-title":"SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms","volume":"16","author":"Vazquez","year":"2021","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00251-019-01106-z","article-title":"Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance","volume":"71","author":"Vijayan","year":"2019","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib81","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1038\/s41467-020-17496-8","article-title":"Structural basis of RNA cap modification by SARS-CoV-2","volume":"11","author":"Viswanathan","year":"2020","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.molimm.2022.11.020_bib82","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.bpj.2021.03.024","article-title":"SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential","volume":"120","author":"Vithani","year":"2021","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.molimm.2022.11.020_bib83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'Kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molimm.2022.11.020_bib84","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.adc9448","article-title":"New subvariants are masters of immune evasion","author":"Vogel","year":"2022","journal-title":"Sci. (N. Y., NY)"},{"issue":"12","key":"10.1016\/j.molimm.2022.11.020_bib85","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrmicro2655","article-title":"Viral subversion of the host protein synthesis machinery","volume":"9","author":"Walsh","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.molimm.2022.11.020_bib86","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.molimm.2022.11.020_bib87","doi-asserted-by":"crossref","first-page":"22550","DOI":"10.1038\/srep22550","article-title":"Activation of innate antiviral immune response via double-stranded RNA-dependent RLR receptor-mediated necroptosis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2022.11.020_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00292","article-title":"Major histocompatibility complex (MHC) Class I and MHC Class II proteins: conformational plasticity in antigen presentation","volume":"8","author":"Wieczorek","year":"2017","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.molimm.2022.11.020_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108761","article-title":"SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO","volume":"34","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108234","article-title":"Evasion of Type I Interferon by SARS-CoV-2","volume":"33","author":"Xia","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2020.11.016","article-title":"Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis","volume":"184","author":"Yan","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib92","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41467-021-26910-8","article-title":"SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis","volume":"12","author":"Yoo","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib93","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1080\/22221751.2020.1780953","article-title":"SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists","volume":"9","author":"Yuen","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"5","key":"10.1016\/j.molimm.2022.11.020_bib94","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41577-022-00715-2","article-title":"ORF9c and ORF10 as accessory proteins of SARS-CoV-2 in immune evasion","volume":"22","author":"Zandi","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2022.11.020_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe7386","article-title":"Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression","volume":"7","author":"Zhang","year":"2021","journal-title":"Sci. Adv."},{"issue":"23","key":"10.1016\/j.molimm.2022.11.020_bib96","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024202118","article-title":"The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-\u0399","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.molimm.2022.11.020_bib97","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41392-020-00438-7","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I\/MDA-5 signaling","volume":"5","author":"Zheng","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"7","key":"10.1016\/j.molimm.2022.11.020_bib98","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1128\/JVI.02570-09","article-title":"The N-terminal region of severe acute respiratory syndrome coronavirus protein 6 induces membrane rearrangement and enhances virus replication","volume":"84","author":"Zhou","year":"2010","journal-title":"J. Virol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589022004874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589022004874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:44:35Z","timestamp":1758980675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589022004874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":98,"alternative-id":["S0161589022004874"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2022.11.020","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2022.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}